Investor Says Stereotaxis Hid Problems With Products

Law360, New York (October 11, 2011, 3:57 PM EDT) -- Stereotaxis Inc. was hit with a putative shareholder class action in Missouri on Friday claiming the medical device maker hid problems with its flagship cardiology treatment systems, resulting in nearly $10 million in losses and the resignation of its chief financial officer.

The suit, filed on behalf of investors who purchased securities between Feb. 28 and Aug. 9, claims Stereotaxis puffed up reports on the demand for its Niobe and Odyssey systems, telling investors the company had an edge on the market and that customer feedback...
To view the full article, register now.




Case Information

Case Title

Pound v. Stereotaxis, Inc. et al

Case Number



Missouri Eastern

Nature of Suit



Henry E. Autrey

Date Filed

October 7, 2011

Law Firms


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.